Overview

An Interaction Study of Ketoconazole/Verapamil Versus AZD1305

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose is to study whether ketoconazole or verapamil have an effect on how AZD1305 is handled by the body, i.e the absorption, distribution, metabolism and excretion, when administered in combination with AZD1305.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Ketoconazole
Verapamil